← back to search

Hannah Obeck

Ludwig-Maximilians-Universität München · DE
Area of research
Oncology · Immunology
Research interest
Research focused on Cancer research and Epithelial cell adhesion molecule, with related work in Immunotherapy, Chimeric antigen receptor, Antagonist. Notable publications include 'Impact of the selective A2AR and A2BR dual antagonist AB928/etrumadenant on CAR T cell function', 'In vivo dynamics and anti-tumor effects of EpCAM-directed CAR T-cells against brain metastases from lung cancer', and '10.01 Effective solid tumor therapy through enhanced recruitment and immune suppression shielded T cells'.
h-index
citations
60
works
3
NIH funding
primary concept
email

Recent publications

<i>In vivo</i> dynamics and anti-tumor effects of EpCAM-directed CAR T-cells against brain metastases from lung cancer
OncoImmunology 2023cited by 20position: middledoi
Impact of the selective A2AR and A2BR dual antagonist AB928/etrumadenant on CAR T cell function
British Journal of Cancer 2022cited by 40position: middledoi
10.01 Effective solid tumor therapy through enhanced recruitment and immune suppression shielded T cells
Oral Presentations 2021cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Sebastian Kobold · German Center for Infection Research3 papers (2021–2023)Theo Lorenzini · Ludwig-Maximilians-Universität München3 papers (2021–2023)Florian Märkl · Ludwig-Maximilians-Universität München2 papers (2021–2022)Arman Öner · Ludwig-Maximilians-Universität München2 papers (2021–2022)Stefan Endres · LMU Klinikum2 papers (2021–2022)Bruno L. Cadilha · University Hospital Regensburg2 papers (2022–2023)Matthias Seifert · Center for Cancer Research2 papers (2021–2022)Mohamed-Reda Benmebarek · Center for Cancer Research1 papers (2022–2022)Jakob Jobst · Ludwig-Maximilians-Universität München1 papers (2022–2022)Jin Zhang · Chongqing Public Health Medical Center1 papers (2022–2022)Wenlong Zhang · Shandong University1 papers (2023–2023)Tao Xu · Guangdong Medical College1 papers (2023–2023)Duc Huynh · Ludwig-Maximilians-Universität München1 papers (2021–2021)MR Benmebarek · LMU Klinikum1 papers (2021–2021)Julika J Herold · Ludwig-Maximilians-Universität München1 papers (2023–2023)Marion Subklewe · Cancer Research Center1 papers (2023–2023)Matthias Mulazzani · Technical University of Munich1 papers (2023–2023)Sophia Stock · German Cancer Research Center1 papers (2022–2022)Stefan Stoiber · Ludwig-Maximilians-Universität München1 papers (2021–2021)Jens Blobner · Ludwig-Maximilians-Universität München1 papers (2023–2023)